---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-006821"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T01:20:19.453049+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vivos Therapeutics raises ~$4.0M via warrant exercise; issues new inducement warrants

## Summary
- Holder exercises Series B warrant for cash at $4.02/share, yielding ~$4.0M gross proceeds.
- Company issues 5-year Series B-1 and 18-month Series B-2 warrants for 735,296 shares each at $5.05.
- Inducement transaction expected to close by Feb 20, 2024; proceeds for working capital.
- A.G.P./Alliance Global Partners receives 7% cash fee ($280K) plus up to $30K legal expenses.
- Company must file resale registration for new warrant shares by Apr 5, 2024.

## SEC filing metadata
- accession: 0001493152-24-006821
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000149315224006821/0001493152-24-006821-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000149315224006821/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-006821
- JSON: https://secwatch.observer/filing/0001493152-24-006821.json
- Plain text: https://secwatch.observer/filing/0001493152-24-006821.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.